Robert Olstein
Olstein Capital Management
Robert Olstein Natus Medical Incorporated stake
total: 342
Olstein Capital Management NTUS trades
- Total transactions:
- 10
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 5
- Held since:
- 2016 Q2
- Held for:
- 10 quarters
- Latest activity:
- 2018 Q4
According to 2026 Q2 report, Robert Olstein doesn't hold any Natus Medical Incorporated (NTUS) shares. To date, the estimated cost basis is nearly $36.34 for "buy" trades and estimated average "sell" price is $36.46. Olstein Capital Management first purchased NTUS in 2016 Q2, initially acquiring 57,025 shares. Since the initial investment in Natus Medical Incorporated (NTUS), Olstein Capital Management has made 9 more transactions.
When did Robert Olstein sell Natus Medical Incorporated (NTUS)?
Robert Olstein sold off the entire Natus Medical Incorporated (NTUS) position in 2018 Q4.
When did Robert Olstein buy Natus Medical Incorporated (NTUS)?
Robert Olstein first invested in Natus Medical Incorporated (NTUS) in 2016 Q2 at the reported quarter-end price of $37.81 per share.
What's the cost basis of Olstein Capital Management's NTUS stake?
The estimated cost basis for Natus Medical Incorporated (NTUS) stake is around $36.34 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $36.34
- Weighted AVG sell price:
- $36.46
Robert Olstein's historical trades in Natus Medical Incorporated
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q4
|
0.00%
|
$35.64
|
-100% (-24,750)
|
|||
|
2018 Q3
|
0.12%
|
$35.64
|
-30.96% (-11,100)
|
|||
|
2018 Q2
|
0.16%
|
$34.50
|
-45.71% (-30,180)
|
|||
|
2018 Q1
|
0.28%
|
$33.65
|
+74.45% (+28,180)
|
|||
|
2017 Q4
|
0.18%
|
$38.20
|
-56.09% (-48,350)
|
|||
|
2017 Q3
|
0.42%
|
$37.51
|
-0.74% (-645)
|
|||
|
2017 Q1
|
0.44%
|
$39.25
|
+11.63% (+9,050)
|
|||
|
2016 Q4
|
0.35%
|
$34.80
|
+39.29% (+21,945)
|
|||
|
2016 Q3
|
0.29%
|
$39.28
|
-2.06% (-1,175)
|
|||
|
2016 Q2
|
0.29%
|
$37.81
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.